| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 137, Issue 11 3515-3520, Copyright © 1986 by American Association of Immunologists
ARTICLES |
YP Huang, PA Miescher and RH Zubler
Interleukin 2 (IL 2) secretion in response to mitogenic stimulation in vitro is strongly reduced in circulating T lymphocytes from patients with SLE. It is still not clear how this abnormality relates to the B cell hyperactivity in the disease. Some investigators proposed that an intrinsic T helper cell defect could lead to suppressor cell dysfunction and autoimmunity. Others have found that in fact increased suppressor cell activity can cause IL 2 hyposecretion. In the present study we report that the IL 2 secretion in response to PHA plus PMA by T cells from patients with SLE, which initially was decreased by a factor of 10 as compared with the IL 2 secretion in blood donor T cells, was restored when the T cells were rested for 2 to 3 days in culture before stimulation. IL 2 hyposecretion in SLE T cells and the kinetics of normalization in culture were not changed by the addition of normal adherent cells during the stimulation with PHA/PMA, occurred in the absence of significant cell death or proliferation or change of the T4:T8 cell ratio during the resting culture, were not due to a maturation of immature T6-positive cells (less than 1.5% T6 cells in SLE T cells), and also occurred in T8-depleted T4 cells alone. Furthermore, a normalization of IL 2 secretion took place in the presence of either SLE serum or normal serum, and the addition of fresh autologous T cells to 3-day-cultured SLE T cells did not cause suppression of IL 2 secretion. These data show that some rapidly reversible defect occurs in circulating T helper cells in SLE. That this could reflect an exhaustion of T helper cells that have been activated in vivo is discussed.
This article has been cited by other articles:
|
|
 |
|
  K. Tsuzaka, Y. Setoyama, K. Yoshimoto, K. Shiraishi, K. Suzuki, T. Abe, and T. Takeuchi A Splice Variant of the TCR {zeta} mRNA Lacking Exon 7 Leads to the Down-Regulation of TCR {zeta}, the TCR/CD3 Complex, and IL-2 Production in Systemic Lupus Erythematosus T Cells J. Immunol., March 15, 2005; 174(6): 3518 - 3525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Saito, S. Nakayamada, K. Nakano, M. Tokunaga, S. Tsujimura, K. Nakatsuka, T. Adachi, and Y. Tanaka Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases Rheumatology, April 1, 2004; 43(4): 479 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tsuzaka, I. Fukuhara, Y. Setoyama, K. Yoshimoto, K. Suzuki, T. Abe, and T. Takeuchi TCR{zeta} mRNA with an Alternatively Spliced 3'-Untranslated Region Detected in Systemic Lupus Erythematosus Patients Leads to the Down-Regulation of TCR{zeta} and TCR/CD3 Complex J. Immunol., September 1, 2003; 171(5): 2496 - 2503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J C Crispin, J Alcocer-Varela, P de Pablo, A Martinez, Y Richaud-Patin, and D Alarcon-Segovia Immunoregulatory defects in patients with systemic lupus erythematosus in clinical remission Lupus, May 1, 2003; 12(5): 386 - 393. [Abstract] [PDF]
|
|
|
|
|
|
M. Aringer, G. H. Stummvoll, G. Steiner, M. Koller, C. W. Steiner, E. Hofler, H. Hiesberger, J. S. Smolen, and W. B. Graninger Serum interleukin-15 is elevated in systemic lupus erythematosus Rheumatology, August 1, 2001; 40(8): 876 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. Ankersmit, N. M. Edwards, M. Schuster, R. John, A. Kocher, E. A. Rose, M. Oz, and S. Itescu Quantitative Changes In T-Cell Populations After Left Ventricular Assist Device Implantation : Relationship to T-Cell Apoptosis and Soluble CD95 Circulation, November 9, 1999; 100(90002): II-211 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B R Lauwerys and F A Houssiau Cytokines: clues to the pathogenesis of SLE Lupus, May 1, 1998; 7(4): 211 - 213. [PDF]
|
|
|
|
|
|
J C Crispin and J Alcocer-Varela Interleukin-2 and systemic lupus erythematosus--fifteen years later Lupus, May 1, 1998; 7(4): 214 - 222. [Abstract] [PDF]
|
|
|
|
|
|
F.-P. Huang and D.I. Stott Dual inhibitory and stimulatory activities in serum from SLE patients and lupus mice that regulate the proliferation of an IL-2-dependent T cell line Lupus, August 1, 1995; 4(4): 297 - 303. [Abstract] [PDF]
|
|
|
|
|
|
D. A. Horwitz, Hua Wang, and J. D. Gray Cytokine Gene Profile in Circulating Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus: Increased Interleukin-2 but not Interleukin-4 mRNA Lupus, October 1, 1994; 3(5): 423 - 428. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Cuadrado, M. Marubayashi, C. Ortega, N. Fernandez-Arcas, F. Garcia-Cozar, J. Pena, P. Sanchez-Guijo, and M. Santamaria Relationship of IL-2, IL-2R (CD25+), Soluble IL-2R and IL-4 with Disease Activity in SLE Patients Lupus, August 1, 1993; 2(4): 257 - 260. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Cuadrado, M. Marubayashi, C. Ortega, N. Fernandez-Arcas, F. Garcia-Cozar, J. Pena, P. Sanchez-Guijo, and M. Santamaria Relationship of IL-2, IL-2R (CD25+), Soluble IL-2R and IL-4 with Disease Activity in SLE Patients Lupus, January 1, 1993; 2(1_suppl): 257 - 260. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
